Humphrey Mulenga

Statistics

Publications

Citations

2.5K

H-Index

Active since

2011

Affiliations

South African Tuberculosis Vaccine Initiative(Current)

University of Cape Town

Stellenbosch University

South African Medical Research Council

University of Oxford

Humphrey Mulenga is an author at South African Tuberculosis Vaccine Initiative specializing in infectious diseases, tuberculosis diagnosis, and tuberculosis diagnostic testing.

ORCID

Publications per year

2011–2025

Publications

Prevention of <i>M. tuberculosis</i> Infection with H4:IC31 Vaccine or BCG Revaccination

Elisa Nemes, Hennie Geldenhuys, Virginie Rozot et al. · New England Journal of Medicine · 2018 · 667 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

Adam Penn‐Nicholson, Stanley Kimbung Mbandi, Ethan Thompson et al. · Scientific Reports · 2020 · 171 citations · Full text

Public Health, Immunology, Infectious Diseases +17

Metabolite changes in blood predict the onset of tuberculosis

January Weiner, Jeroen Maertzdorf, Jayne S. Sutherland et al. · Nature Communications · 2018 · 159 citations · Full text

Life Sciences, Biochemistry, Molecular Medicine +17

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Thomas J. Scriba, Andrew Fioré-Gartland, Adam Penn‐Nicholson et al. · The Lancet Infectious Diseases · 2021 · 154 citations · Full text

Public Health, Community Health, Preventive Medicine +17

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

Michèle Tameris, Helen Mearns, Adam Penn‐Nicholson et al. · The Lancet Respiratory Medicine · 2019 · 137 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

1–5 of 35